Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Pinelabs IPO Review - Another Fintech IPO Exactly 4yrs After Paytm - Can It Buck the Trend?

Equity Bottom-Up

<ul>
<li>Pine Labs has filed RHP for IPO with a total offer size of up to INR 39B, offering 176.5M shares at a price band of INR 210-INR 221 per share.</li>
<li>This includes a fresh issue of INR 20.8B (~ 94.1M shares). The company intends to use the proceeds for debt repayment, cloud infrastructure and technology, general corporate purpose etc.</li>
<li>Our recommendation would be that investors whoever is looking at a long-term investment horizon can definitely look at the stock as a growing long-term bet.</li>
</ul>


Pine Labs has filed RHP for IPO with a total offer size of up to INR 39B, offering 176.5M shares at a price band of INR 210-INR 221 per share.
This includes a fresh issue of INR 20.8B (~ 94.1M shares). The company intends to use the proceeds for debt repayment, cloud infrastructure and technology, general corporate purpose etc.
Our recommendation would be that investors whoever is looking at a long-term investment horizon can definitely look at the stock as a growing long-term bet.


Pine Labs IPO: Market Position and Scalability Offers a Long-Term Digital Growth Story